Recon: Teva, Allergan willing to pay $5B to settle opioid suits; FTC tells Medtronic to divest Fiagon in Intersect takeover
ReconMichael Mezher
Biologics/ biosimilars/ vaccinesBiotechnologyDiagnostics/IVDsEuropeGlobalMedical DevicesNorth AmericaPharmaceuticalsRegulatory Intelligence/Policy